U.S. markets closed
  • S&P Futures

    3,688.00
    -21.00 (-0.57%)
     
  • Dow Futures

    29,518.00
    -151.00 (-0.51%)
     
  • Nasdaq Futures

    11,318.00
    -58.75 (-0.52%)
     
  • Russell 2000 Futures

    1,676.60
    -9.50 (-0.56%)
     
  • Crude Oil

    78.33
    -0.41 (-0.52%)
     
  • Gold

    1,646.10
    -9.50 (-0.57%)
     
  • Silver

    18.51
    -0.40 (-2.12%)
     
  • EUR/USD

    0.9639
    -0.0049 (-0.51%)
     
  • 10-Yr Bond

    3.6970
    -0.0110 (-0.30%)
     
  • Vix

    29.92
    +2.57 (+9.40%)
     
  • GBP/USD

    1.0501
    -0.0356 (-3.28%)
     
  • USD/JPY

    143.9420
    +0.6220 (+0.43%)
     
  • BTC-USD

    18,866.68
    -174.68 (-0.92%)
     
  • CMC Crypto 200

    433.08
    -11.45 (-2.58%)
     
  • FTSE 100

    7,018.60
    -140.92 (-1.97%)
     
  • Nikkei 225

    26,524.81
    -629.02 (-2.32%)
     

Silk Road Medical to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

·1 min read
Silk Road Medical
Silk Road Medical

SUNNYVALE, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in a fireside chat at the upcoming Morgan Stanley 20th Annual Global Healthcare Conference held in New York, New York.

Silk Road Medical’s management is scheduled to present on Tuesday, September 13, 2022 at 12:55 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.silkroadmed.com/.

About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, and Plymouth, Minnesota, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.

Investor Contact:
Lynn Lewis or Marissa Bych
Gilmartin Group
investors@silkroadmed.com

Media:
Michael Fanucchi
Silk Road Medical
mfanucchi@silkroadmed.com